Drug of choice for absence seizures?

Prepare for the Manor Preboards Model Test. Utilize flashcards and multiple-choice questions, each offering hints and explanations. Enhance your readiness and succeed on your exam!

Multiple Choice

Drug of choice for absence seizures?

Explanation:
Absence seizures arise from abnormal thalamocortical oscillations that rely on low-threshold T-type calcium channels in thalamic neurons. Ethosuximide targets these channels, reducing the T-type calcium currents and dampening the rhythmic bursts that produce absence seizures. This focused mechanism makes it highly effective for absence seizures and usually with a gentler cognitive side‑effect profile, so it’s the preferred first-line treatment for this seizure type. Phenytoin and carbamazepine are sodium-channel blockers suited to focal or generalized tonic-clonic seizures; they don’t address the thalamocortical bursts that underlie absence and can even worsen absence symptoms. Valproic acid is effective against multiple seizure types, including absence, but carries higher risks such as hepatotoxicity and teratogenicity, especially in women of childbearing potential.

Absence seizures arise from abnormal thalamocortical oscillations that rely on low-threshold T-type calcium channels in thalamic neurons. Ethosuximide targets these channels, reducing the T-type calcium currents and dampening the rhythmic bursts that produce absence seizures. This focused mechanism makes it highly effective for absence seizures and usually with a gentler cognitive side‑effect profile, so it’s the preferred first-line treatment for this seizure type.

Phenytoin and carbamazepine are sodium-channel blockers suited to focal or generalized tonic-clonic seizures; they don’t address the thalamocortical bursts that underlie absence and can even worsen absence symptoms. Valproic acid is effective against multiple seizure types, including absence, but carries higher risks such as hepatotoxicity and teratogenicity, especially in women of childbearing potential.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy